An estimated 141,054 people in Rhode Island live with migraine.
Based on U.S. Census ACS 2023 population data and Burch et al. (2021) migraine-specific prevalence rates.
Census ACS 2023 · Burch et al. (2021) · CC BY 4.0
Patient Population by Care Level
How many patients need each level of care.
* Care level estimates are based on a proposed patient complexity framework offered as a basis for clinical and policy discussion. See methodology →
By Congressional District
2 congressional districts in Rhode Island
* Care level estimates are based on a proposed patient complexity framework offered as a basis for clinical and policy discussion. See methodology →
Headache Centers & Programs
Rhode Island has no Level 1 or Level 2 headache centers.
There are no UCNS-certified headache centers or formal headache programs in Rhode Island. Patients who need specialist or headache program-level care must travel out of state or access care via telehealth.
Provider counts reflect headache program providers only — not all neurologists at the same address. UCNS certification verified against the United Council for Neurologic Subspecialties diplomate directory.
More Data Coming
Building a complete picture.
Payer Policy Data
What insurers in Rhode Island require before authorizing CGRP-targeting therapies — step therapy requirements, formulary placements, and Gold Card law status.
Prescribing Gap Analysis
How many primary care physicians actively treating migraine patients in Rhode Island have never prescribed a CGRP-targeting therapy — by metro area and congressional district.
Doty A. Rhode Island Headache Disorder Population Estimates.
The Headache Vault; 2026.
headachevault.com/research/states/rhode-island
Licensed CC BY 4.0.